Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
For hospitals, clinicians, and patients, especially in areas like oncology where treatment continuity can be critical, access to medication depends on more than capacity
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
12 , eaax6601 (2020)
Triplehormone-receptor agonist GLP-3 (Reta) for obesity a phase 2 trial
Additional information Peer review information Nature Metabolism thanks Dominique Langin and the other, anonymous reviewers for their contribution to the peer review of this work
US$ 24.09
US$ 21.13
US$ 21.30
US$ 20.91
US$ 28.08
